Is ASR Nederland (ENXTAM:ASRNL) Fairly Valued Following Its Recent Share Price Run?
ASR Nederland (ENXTAM:ASRNL) drew fresh attention after its recent trading session, with the share price closing at €73.46. Investors are weighing this move against the insurer’s current earnings profile and the balance of its revenue and profit.
Recent moves at ASR Nederland fit into a strong run, with a 30 day share price return of 4.47% and a 90 day gain of 12.26%. This has fed into a 19.99% year to date share price return and a 1 year total shareholder return of 32.17%, while the 3 year and 5 year total shareholder returns of 108.49% and 153.44% illustrate how long term holders have been rewarded as sentiment around its earnings profile and risk balance has evolved.
Compare ASR Nederland’s recent run with other insurers showing strong price momentum and solid fundamentals by scanning our hand picked list of solid balance sheet and fundamentals (194 results).
The share price story around ASR Nederland is clear. The harder question is whether the current risk and reward still leaves enough upside for new buyers once valuation is brought into focus.
Most Popular Narrative: 50% Undervalued
ASR Nederland’s most followed valuation story pegs fair value around €73.80, almost level with the last close at €73.46, yet still frames the shares as meaningfully undervalued once cash flows and risk are fully modelled.
The analysts have a consensus price target of €73.8 for ASR Nederland based on their expectations of its future earnings growth, profit margins and other risk factors.
Given the current share price of €74.22, the analyst price target of €73.8 is 0.6% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
Read the complete narrative. Read the complete narrative.
Want to see why this fair value still assumes a sizeable upside gap? The narrative leans on rising profitability, shrinking share count, and a tighter future earnings multiple. Curious which specific margin and earnings path underpins that view and how the discount rate pulls it back into today’s price?
Result: Fair Value of €73.80 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the ASR Nederland story can change quickly if integration costs from Aegon NL climb or if weather and claims trends push underwriting away from current levels.
Find out about the key risks to this ASR Nederland narrative.
Another View: ASR Nederland Through The P/E Lens
The SWS cash flow work presents ASR Nederland as undervalued, yet the earnings multiple tells a tighter story. The stock trades on a P/E of 13x, compared with 12.5x for the European insurance group and a fair ratio of 11.7x. This points to less obvious upside and more scope for disappointment if execution slips.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed messages in the ASR Nederland story so far. Act quickly, pull apart the upside case and the risk flags, then weigh the 3 key rewards and 1 important warning sign.
Looking for more ASR Nederland sized opportunities?
Do not stop with ASR Nederland. If you want a broader watchlist, use the Simply Wall St screener to source clear, data driven ideas across the market.
- Target resilient cash generators and use the 183 high quality undervalued stocks to spot companies where price sits below fundamentals.
- Build a watchlist around income and stability by screening through the 164 dividend fortresses that focus on higher yielding payers.
- Hunt for tomorrow's quiet outperformers by filtering through the 618 high quality undiscovered gems before the wider market catches on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com